Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006503
Status:
COMPLETED
Last Update Posted:
2014-05-01
First Post:
2000-11-16
Brief Title:
Prevalence Progression of Subclinical Atherosclerosis
Sponsor:
Rush University Medical Center
Organization:
Rush University Medical Center
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate subclinical atherosclerotic disease in menopausal women
Detailed Description:
BACKGROUND
Decreased ovarian function and premenopausal obesity are likely the primary determinants of early coronary atherosclerosis as measured by calcification on EBCT Aortic calcification occurs earlier than coronary calcification may predict coronary calcification and is expected to be the best marker of risk associated with traditional factors in these younger women Preliminary data indicate that changes in coronary and aortic calcification can be observed over short periods of time in these women A period of diminishing estrogen levels is the optimum time to observe changes in endothelial function which likely precede measurable atherosclerosis and thus may be the earliest markers for disease potential Vascular stiffness a marker for the biologic aging of the vascular system is highly correlated with measures of insulin sensitivity which is altered in women at mid-life in conjunction with increases in central adiposity Racial differences in disease prevalence and the relative importance of certain risk factors are likely
DESIGN NARRATIVE
Subclinical atherosclerosis will be evaluated in 728 women 305 African American 423 Caucasian enrolled in the Pittsburgh and Chicago sites of the Study of Womens Health Across the Nation SWAN a multicenter study characterizing the biological and psychosocial antecedents and sequellae of menopause The extent to which diminishing ovarian function affects vascular function and accelerates the development of atherosclerosis in the coronary arteries aorta and carotid arteries will be evaluated Serial measures of coronary and aortic calcification by electron beam computed tomography EBCT carotid atherosclerosis endothelial function and aortic stiffening will be performed two years apart The prevalence and progression of subclinical atherosclerosis will be evaluated in relation to serial measures of ovarian function psychosocial and behavioral factors markers of clotting and inflammation as well as traditional cardiovascular risk factors all collected in SWAN The study is conducted jointly by Dr Lynda Powell R01HL65581 at Rush-Presbyterian-St Lukes Medical Center in Chicago and Dr Kim Tyrrell R01HL65591 at the University of Pittsburgh
Decreased ovarian function and premenopausal obesity are likely the primary determinants of early coronary atherosclerosis as measured by calcification on EBCT Aortic calcification occurs earlier than coronary calcification may predict coronary calcification and is expected to be the best marker of risk associated with traditional factors in these younger women Preliminary data indicate that changes in coronary and aortic calcification can be observed over short periods of time in these women A period of diminishing estrogen levels is the optimum time to observe changes in endothelial function which likely precede measurable atherosclerosis and thus may be the earliest markers for disease potential Vascular stiffness a marker for the biologic aging of the vascular system is highly correlated with measures of insulin sensitivity which is altered in women at mid-life in conjunction with increases in central adiposity Racial differences in disease prevalence and the relative importance of certain risk factors are likely
DESIGN NARRATIVE
Subclinical atherosclerosis will be evaluated in 728 women 305 African American 423 Caucasian enrolled in the Pittsburgh and Chicago sites of the Study of Womens Health Across the Nation SWAN a multicenter study characterizing the biological and psychosocial antecedents and sequellae of menopause The extent to which diminishing ovarian function affects vascular function and accelerates the development of atherosclerosis in the coronary arteries aorta and carotid arteries will be evaluated Serial measures of coronary and aortic calcification by electron beam computed tomography EBCT carotid atherosclerosis endothelial function and aortic stiffening will be performed two years apart The prevalence and progression of subclinical atherosclerosis will be evaluated in relation to serial measures of ovarian function psychosocial and behavioral factors markers of clotting and inflammation as well as traditional cardiovascular risk factors all collected in SWAN The study is conducted jointly by Dr Lynda Powell R01HL65581 at Rush-Presbyterian-St Lukes Medical Center in Chicago and Dr Kim Tyrrell R01HL65591 at the University of Pittsburgh
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01HL065581 | NIH | None | httpsreporternihgovquickSearchR01HL065581 |